Targeting the Intracellular WT1 Oncogene Product with a Therapeutic Human Antibody-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting the Intracellular WT1 Oncogene Product with a Therapeutic Human Antibody

Published:2013-03-13 Issue:176 Volume:5 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Dao Tao¹,Yan Su²,Veomett Nicholas¹³,Pankov Dmitry¹,Zhou Liang²,Korontsvit Tatyana¹,Scott Andrew¹,Whitten Joseph¹,Maslak Peter¹,Casey Emily¹,Tan Taochao²,Liu Hong²,Zakhaleva Victoria¹,Curcio Michael¹,Doubrovina Ekaterina¹,O’Reilly Richard J.¹³,Liu Cheng²,Scheinberg David A.¹³

Affiliation:

1. Molecular Pharmacology and Chemistry Program, Immunology Program, Departments of Medicine, Pediatrics, Pathology, and Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

2. Eureka Therapeutics, Emeryville, CA 94608, USA.

3. Weill Cornell Medical College, New York, NY 10021, USA.

Abstract

A therapeutic monoclonal antibody specific for the intracellular oncoprotein Wilms tumor 1 treats human leukemias in mice.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference50 articles.

1. Antibody-Based Immunotherapy of Cancer

2. Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma

3. Antibody therapy of cancer

4. Immune recognition of self in immunity against cancer

5. Unique Tumor Antigens: Evidence for Immune Control of Genome Integrity and Immunogenic Targets for T Cell–Mediated Patient-Specific Immunotherapy

Cited by 158 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA self-assembly-mediated high drug-antibody ratio ADC platform for targeted tumor therapy and imaging;Nano Today;2024-10

2. Generation and evaluation of cancer binding capacity of HLA-A2-WT1 complex-targeting antibody;Immunology Letters;2024-08

3. The rebirth of epitope-based patent claims;Human Antibodies;2024-06-11

4. Pin1-Catalyzed Conformation Changes Regulate Protein Ubiquitination and Degradation;Cells;2024-04-23

5. Preclinical evaluation of a novel CAR-T therapy utilizing a scFv antibody highly specific to MAGE-A4p230-239/HLA-A∗02:01 complex;Molecular Therapy;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3